Subject(s)
Ambulatory Care , Arrhythmias, Cardiac/therapy , COVID-19/prevention & control , Cardiac Conduction System Disease/therapy , Cardiac Pacing, Artificial , Cardiac Resynchronization Therapy , Delivery of Health Care/methods , Patient Satisfaction , Aged , Aged, 80 and over , Cardiac Electrophysiology , Cardiac Resynchronization Therapy Devices , Death, Sudden, Cardiac/prevention & control , Defibrillators, Implantable , Female , Humans , Infection Control , Male , Pacemaker, Artificial , Patient Preference , Personal Protective Equipment , SARS-CoV-2 , Surgical Wound Infection/diagnosisABSTRACT
The beginning of 2020 was characterized by the development of a new coronavirus pandemic (COVID-19). Information about the epidemiology, etiology, pathogenesis, clinical and laboratory diagnostics, as well as prevention and therapy for this disease is constantly being expanded and reviewed. The COVID-19 pandemic creates the need for the emergence of new conditions of specialized care for patients with heart rhythm and conduction disorders [1]. These recommendations are intended for general practitioners, internists, cardiologists, electrophysiologists/arrhythmologists, cardiovascular surgeons, functional diagnostics doctors, anesthesiologists-resuscitators, laboratory diagnostics specialists, health care organizers in the system of organizations and healthcare institutions that provide specialized care to patients with heart rhythm and conduction disorders.